About Technology Issues FAQ

Links

Phase II Study of Cetuximab As First-Line Single-Drug Therapy in Patients With Unresectable Squamous Cell Carcinoma of the Skin

Phase II Study of Cetuximab As First-Line Single-Drug Therapy in Patients With Unresectable Squamous Cell Carcinoma of the Skin — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.